---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-135011"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2023-05-04T23:59:59+00:00"
generated_at: "2026-06-15T23:33:27.210897+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health Q3 revenue +13% to $50.5B; raises FY23 non-GAAP EPS guidance to $5.60-$5.80

## Summary
- Revenue $50.5B (+13% YoY); GAAP EPS $1.34 (vs -$5.05 loss); Non-GAAP EPS $1.74 (+20% YoY).
- Pharmaceutical segment profit $600M (+23%); Medical segment profit $20M (-66%).
- FY23 non-GAAP EPS guidance raised to $5.60-$5.80 from $5.20-$5.50; adjusted FCF raised to $2.0-$2.3B.
- Cooperation agreement with Elliott extended to July 15, 2024; Business Review Committee extended similarly.
- Pharmaceutical profit growth outlook raised to 10.5%-12%; Medical profit outlook lowered to ~50% decline.

## SEC filing metadata
- accession: 0001193125-23-135011
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2023-05-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000119312523135011/0001193125-23-135011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000119312523135011/d358353d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-135011
- JSON: https://secwatch.observer/filing/0001193125-23-135011.json
- Plain text: https://secwatch.observer/filing/0001193125-23-135011.txt

## Key facts
- Earnings Releases
  CARDINAL HEALTH INC reported third quarter fiscal year 2023 (quarter ended March 31, 2023) results: revenue $50.5 billion, net income $345 million, EPS $1.34. Guidance raised.
  - Period: third quarter fiscal year 2023 (quarter ended March 31, 2023)
  - Revenue: $50.5 billion
  - Net income: $345 million
  - EPS: $1.34
  - Guidance: raised
  - Result: reported results
  source text: Today reported third quarter fiscal year 2023 revenues of $50.5 billion, an increase of 13% from the third quarter of fiscal year 2022. Third quarter GAAP operating earnings were $572 million and GAAP diluted earnings per share (EPS) were $1.34.
  evidence_url: https://www.sec.gov/Archives/edgar/data/721371/000119312523135011/0001193125-23-135011-index.htm
- Material Agreements
  CARDINAL HEALTH INC amended First Amendment with Elliott Associates, L.P., Elliott International, L.P., Elliott International Capital Advisors Inc. (effective 2023-05-03).
  - Action: amendment
  - Counterparty: Elliott Associates, L.P., Elliott International, L.P., Elliott International Capital Advisors Inc.
  - Effective: 2023-05-03
  source text: On May 3, 2023, Cardinal Health, Inc., (the “Company”) entered into a First Amendment (the “Amendment”) to the Cooperation Agreement (the “Cooperation Agreement”) dated September 5, 2022 by and among Elliott Associates, L.P., Elliott International, L.P. and Elliott International Capital Advisors Inc. and the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/721371/000119312523135011/0001193125-23-135011-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.